SB2227: Preventing the Financing of Illegal Synthetic Drugs Act
- 1Introduced (current step)
- 2Passed One Chamber
- 3Passed Both Chambers
- 4Became Law
Here is how to read this bill
Start with the summary
It says what the bill does in plain language. The official text is one tab over.
Check where it is
The status badge says how far it has gotten. The History tab lists every step.
Follow it
We will email you when it moves. You need a free account.
Tell someone who votes on it
Email or call the sponsor, or find your own representatives, from the actions panel.
Bill information
Summary
A bill to require the Comptroller General of the United States to carry out a study on the trafficking into the United States of synthetic drugs, and related illicit finance, and for other purposes.
Plain-language summary
This bill directs the Comptroller General—a government official who audits federal spending—to study how synthetic drugs enter the United States and how criminals finance this illegal trade. Synthetic drugs are human-made substances like fentanyl and designer drugs that mimic other narcotics. The bill affects law enforcement, financial regulators, and policymakers who work on drug trafficking. Currently, the bill has been introduced in Congress but has not yet been assigned to a for debate.
AI-generated summary
What can I do?
It's early in the process — messages to the sponsor and your representatives carry the most weight right now.
Contact Your Representatives
Calling or emailing is the most direct way to weigh in — offices tally constituent contacts.
Find Your RepresentativesShare This Bill
Sharing helps others in your district get informed and involved.
SB2227: Preventing the Financing of Illegal Synthetic Drugs Act